| Giralt M, Navas V, Hernández-Nieto L, et al.
[Retrospective analysis of the efficacy and tolerability of anagrelide in patients with essential thrombocytemia: Spanish registry of essential thrombocytemia.] [JOURNAL ARTICLE]
Med Clin (Barc) 2009 Jun 5.
Abstract | Full Citation | | Proietti R, Rognoni A, Ardizzone F, et al.
Atypical Takotsubo syndrome during anagrelide therapy. [JOURNAL ARTICLE]
J Cardiovasc Med (Hagerstown) 2009 Apr 23.
Abstract | Full Citation | Find Related Articles | | Campbell PJ, Bareford D, Erber WN, et al.
Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy. [JOURNAL ARTICLE]
J Clin Oncol 2009 Apr 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Petrides PE, Gisslinger H, Steurer M, et al.
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation. [Journal Article]
Clin Ther 2009 Feb; 31(2):386-98.
Abstract | Full Citation | | Larsen TS, Pallisgaard N, de Stricker K, et al.
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden. [Journal Article]
Hematology 2009 Feb; 14(1):11-5.
Abstract | Full Citation | Find Related Articles | | Reilly JT
Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists. [Journal Article]
Hematology 2009 Feb; 14(1):1-10.
Abstract | Full Citation | Find Related Articles | | Christoforidou A, Pantelidou D, Anastasiadis A, et al.
Hydroxyurea and Anagrelide Combination Therapy in Patients with Chronic Myeloproliferative Diseases Resistant or Intolerant to Monotherapy. [JOURNAL ARTICLE]
Acta Haematol 2009 Jan 8; 120(4):195-198.
Full Citation | Publisher Full Text | Find Related Articles | | Emadi A, Spivak JL
Anagrelide: 20 years later. [Journal Article]
Expert Rev Anticancer Ther 2009 Jan; 9(1):37-50.
Abstract | Full Citation | Find Related Articles | | D'adda M, Micheletti M, Drera M, et al.
The combined use of hydroxyurea and anagrelide allows satisfactory hematologic control in patients with chronic myeloproliferative disorders and thrombocytosis: a report on 13 patients with poor tolerance to hydroxyurea monotherapy. [LETTER]
Leuk Lymphoma 2008 Nov; 49(11):2216-2218.
Full Citation | | Boban A, Sertić D, Radman I, et al.
[Anagrelide for treatment of patients with essential thrombocythaemia] [English Abstract, Journal Article]
Lijec Vjesn 2008 May-Jun; 130(5-6):141-5.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
